SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-14-000044
Filing Date
2014-04-21
Accepted
2014-04-21 17:10:54
Documents
5
Effectiveness Date
2014-04-21

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2014proxynoticecard.htm DEFA14A 27732
2 proxcard1.jpg GRAPHIC 91560
3 proxycard2.jpg GRAPHIC 121746
4 proxycard3.jpg GRAPHIC 57707
5 proxycard4.jpg GRAPHIC 38125
  Complete submission text file 0000886163-14-000044.txt   455182
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 14774438
SIC: 2834 Pharmaceutical Preparations